Loading clinical trials...
Loading clinical trials...
Comparison of Steatosis and Fibrosis Measurements From Velacur and MRE/MRI-PDFF in Patients With Chronic Liver Disease
Conditions
Interventions
Velacur
Locations
2
United States
GI Alliance-Flowood, MS
Flowood, Mississippi, United States
GI Alliance-Webster, TX
Webster, Texas, United States
Start Date
July 15, 2023
Primary Completion Date
December 30, 2023
Completion Date
January 31, 2024
Last Updated
June 18, 2023
NCT06218589
NCT03151473
NCT02754037
NCT07172997
NCT07268937
NCT05051527
Lead Sponsor
GI Alliance
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions